Listed
2025-09
First close
USD 14.24
split-adjusted
Since listing
+469%
392 points—
Current
USD 80.96
$20.1 B · 2026-11-20 16:00 ET
Peak
USD 82.82
$20.5 B2026-11
Low
USD 80.30
$19.9 B2026-11
Latest change
-0.5%
Prior close → 16:00
Change since first
-0.5%
2026-11
52-week range
USD 79.52 – USD 124.00
Drawdown
-34.7%
Avg vol 3m
1.1M
Price history
Last session · Nov 20Nov 20, 2026
Monthly closes from Yahoo Finance, split-adjusted, dividends excluded. Earlier points are actual closes, not reconstructed.
Time (ET)CloseMarket capChange
- 16:00USD 80.96$20.1 B-0.5%
- 15:59USD 80.77$20 B-0.8%
- 15:58USD 80.78$20 B-0.7%
- 15:57USD 80.75$20 B-0.8%
- 15:56USD 80.83$20 B-0.7%
- 15:55USD 80.89$20.1 B-0.6%
- 15:54USD 80.90$20.1 B-0.6%
- 15:53USD 80.94$20.1 B-0.5%
- 15:52USD 80.91$20.1 B-0.6%
- 15:51USD 81.06$20.1 B-0.4%
- 15:50USD 81.08$20.1 B-0.4%
- 15:49USD 81.02$20.1 B-0.4%
- 15:48USD 80.89$20.1 B-0.6%
- 15:47USD 80.90$20.1 B-0.6%
- 15:46USD 80.99$20.1 B-0.5%
- 15:45USD 80.73$20 B-0.8%
- 15:44USD 80.78$20 B-0.7%
- 15:43USD 80.80$20 B-0.7%
- 15:42USD 80.78$20 B-0.7%
- 15:41USD 80.80$20 B-0.7%
Ownership & Control
Latest available filings- Controlling entity
- Publicly held — no controlling shareholder disclosed
- Insiders
- —
- Institutions
- —
- Free float
- —
Percentages are of total shares outstanding, aggregated from 13F-style filings via Yahoo Finance. Institutional figures reflect US-filed positions and may undercount owners filing elsewhere. No figure is shown where none is disclosed.
In the press
All coverage →- BioNTech SE Q3FY26 Results: Earnings call set for November 3 - scanx.trade2026-10-20
- BioNTech to Report Third Quarter 2026 Financial Results and Corporate Update on November 3, 2026 - www.marketscreener.com2026-10-20
- BioNTech (BNTX) will present first results for two cancer drug combinations - Stock Titan2026-10-19
